Gut Pathogens

Scope & Guideline

Connecting the Dots Between Gut Health and Infectious Threats

Introduction

Immerse yourself in the scholarly insights of Gut Pathogens with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1757-4749
PublisherBMC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2009 to 2024
AbbreviationGUT PATHOG / Gut Pathogens
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Gut Pathogens' primarily focuses on the intricate relationship between gut microbiota, pathogens, and gastrointestinal diseases. It encompasses a wide array of research methodologies, including clinical studies, microbiological analyses, genomic sequencing, and meta-analyses, contributing to a deeper understanding of gut health and disease mechanisms.
  1. Microbiota-Pathogen Interactions:
    Research exploring how various gut microbes interact with pathogens, influencing infection outcomes and disease progression.
  2. Gastrointestinal Infections and Pathogens:
    Studies focusing on the prevalence, virulence, and antimicrobial resistance of gastrointestinal pathogens, including bacteria, viruses, and parasites.
  3. Therapeutic Interventions:
    Investigations into probiotics, fecal microbiota transplantation, and other therapeutic approaches aimed at restoring gut health and combating infections.
  4. Metagenomics and Microbial Ecology:
    Utilization of advanced genomic techniques to analyze gut microbiome composition and its fluctuations in health and disease.
  5. Clinical Outcomes and Risk Factors:
    Assessment of clinical outcomes associated with gut infections and the identification of risk factors that predispose individuals to gastrointestinal diseases.
  6. Emerging Pathogens and Resistance Mechanisms:
    Focus on the emergence of new pathogens and the mechanisms behind antimicrobial resistance in gut-associated microbes.
Recent publications in 'Gut Pathogens' highlight several emerging themes that reflect the journal's evolving focus. The following areas have gained traction, indicating a shift in research priorities and emerging interests within the field.
  1. Microbiome Influence on Mental Health:
    A rising interest in the links between gut microbiota and mental health conditions, such as depression and anxiety, showcases the expanding understanding of the gut-brain axis.
  2. Fecal Microbiota Transplantation (FMT):
    Increasing studies on FMT as a therapeutic option for various gastrointestinal diseases underline its relevance and potential as a treatment strategy.
  3. Resistance Mechanisms and Antimicrobial Stewardship:
    Research focusing on the mechanisms of antimicrobial resistance in gut pathogens and strategies for effective antimicrobial stewardship is becoming a focal point.
  4. In Vitro and In Vivo Models:
    The development of structured multicellular models and animal models for studying gut infections and microbiota interactions is gaining attention, promoting innovative research methodologies.
  5. Omics Technologies in Gut Research:
    The application of multi-omics technologies (metagenomics, metabolomics) for understanding gut health and disease is trending, providing comprehensive insights into microbial functions and interactions.
  6. Global Health and One Health Approaches:
    An increasing emphasis on the One Health framework, integrating human, animal, and environmental health perspectives in understanding gut pathogens and their transmission.

Declining or Waning

While 'Gut Pathogens' has consistently focused on the interrelationship between gut microbiota and gastrointestinal diseases, certain themes have shown a decline in prominence over recent years. This section outlines those waning areas of interest.
  1. Traditional Antibiotic Treatments:
    As the focus shifts towards understanding the microbiome and its therapeutic potentials, traditional antibiotic treatments are being discussed less frequently compared to novel approaches like phage therapy and probiotics.
  2. Non-Gastrointestinal Focused Pathogens:
    Research specifically targeting pathogens outside the gastrointestinal tract has decreased, as the journal narrows its scope to more directly relevant gut pathogens.
  3. Basic Microbial Characterization:
    The emphasis on basic microbial characterization without clinical or therapeutic implications is waning, as studies increasingly aim to connect findings with clinical outcomes and therapeutic strategies.
  4. Generalized Epidemiological Studies:
    There is a reduction in generalized epidemiological studies that do not delve into the mechanisms of disease or gut microbiome interactions, with a greater focus now on detailed mechanistic studies.

Similar Journals

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Connecting researchers to advance immunological science.
Publisher: ELSEVIER TAIWANISSN: 1684-1182Frequency: 6 issues/year

Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.

Indian Journal of Medical Microbiology

Bridging Science and Clinical Practice in Microbiology
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Infectious Disease Reports

Advancing global health through groundbreaking research.
Publisher: MDPIISSN: Frequency: 6 issues/year

Infectious Disease Reports is a premier open-access journal published by MDPI, dedicated to advancing the field of infectious diseases. Since its inception in 2009, this journal has established itself as a significant platform for disseminating cutting-edge research, reviews, and case studies, critical for global health. With a commendable Q2 ranking in the category of Infectious Diseases and a Scopus rank of #140 out of 344, it is recognized for its impactful contributions to medical research, holding a 59th percentile in its field. The journal aims to provide comprehensive insights into various dimensions of infectious diseases, ranging from epidemiology to novel treatment modalities. As an open-access publication, Infectious Disease Reports ensures that its articles are freely available to a wide audience, fostering collaborative efforts among researchers, healthcare professionals, and students worldwide. With its ongoing commitment to excellence, the journal plays an essential role in shaping the future of infectious disease research.

Malaysian Journal of Microbiology

Championing Innovation in Microbiology and Biotechnology
Publisher: MALAYSIAN SOC MICROBIOLOGYISSN: 1823-8262Frequency: 6 issues/year

Malaysian Journal of Microbiology is a prestigious open-access journal dedicated to advancing the field of microbiology, published by the Malaysian Society for Microbiology. Since its inception in 2005, this journal has become an essential platform for researchers and practitioners, facilitating the dissemination of innovative studies in applied microbiology, biotechnology, and infectious diseases. Based in Penang, Malaysia, this journal not only focuses on local microbiological research but also positions itself within the broader global scientific community. Although currently placed in the Q4 category in several relevant fields—including Applied Microbiology and Biotechnology, Infectious Diseases, and Medical Microbiology according to the 2023 Scopus rankings—it plays a crucial role in encouraging novel research and fostering collaboration among scientists. The journal encourages submissions that contribute to the understanding of microbial processes, disease mechanisms, and novel biotechnological applications, thereby supporting the continuous growth of knowledge in microbiology. With open access since its launch, the Malaysian Journal of Microbiology ensures that all published works are freely available to the public, enhancing their visibility and impact within the scientific community.

MIKROBIYOLOJI BULTENI

Unveiling the Complexities of Microbial Life
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

New Microbes and New Infections

Advancing knowledge on the frontlines of infectious diseases.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

Bioscience of Microbiota Food and Health

Bridging Microbiology and Nutrition for a Healthier Tomorrow
Publisher: BMFH PRESSISSN: 2186-6953Frequency: 4 issues/year

Bioscience of Microbiota Food and Health, an esteemed journal published by BMFH PRESS, serves as a pivotal platform for interdisciplinary research in the expanding fields of applied microbiology, food science, and gastroenterology. Since its inception in 2014, the journal has facilitated a critical exchange of scientific knowledge, promoting advancements in our understanding of microbiota's role in human health and nutrition. With its impressive 2023 category quartile rankings—Q2 in Applied Microbiology and Biotechnology, Food Science, and Gastroenterology—it stands out among its peers, appealing to researchers, professionals, and students alike. The journal does not follow an open-access model, which underscores its exclusivity while maintaining rigorous peer-review standards. Based in Japan, it provides a global forum for innovative studies that advance the field and enhance public health outcomes. As the journal converges into its next decade, it continues to uphold its commitment to disseminating high-quality research that bridges the gap between microbiota, food, and human health.

Gastroenterology Research and Practice

Transforming Insights into Improved Patient Care
Publisher: HINDAWI LTDISSN: 1687-6121Frequency:

Gastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.

Korean Journal of Gastroenterology

Your Gateway to Gastrointestinal Research and Innovation
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Klimik Journal

Championing Open Access for Global Health Advancement.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 1301-143XFrequency: 4 issues/year

Klimik Journal is a pivotal publication in the fields of Infectious Diseases and Medical Microbiology, serving as a platform for researchers, clinicians, and academics to disseminate groundbreaking findings and improve health outcomes. Established in 2010 and published by DOC DESIGN INFORMATICS CO LTD, this journal is dedicated to advancing knowledge and fostering discussions around critical issues in infectious diseases and microbial research. With an ISSN of 1301-143X and an E-ISSN of 1309-1484, Klimik Journal strives to maintain high academic standards despite currently ranking in the fourth quartile in both categories according to Scopus metrics, which highlights the need for continued contributions to the field. Operating from Turkey, the journal is committed to supporting open access options, thereby ensuring wide dissemination of research findings. As it continues to bridge the gap between theory and practice, Klimik Journal is poised to become an essential resource for those looking to stay at the forefront of infectious disease research and microbiological advancements.